More information: Silvia Vaena et al, Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response, Cell Reports (2021). DOI: 10.1016/j.celrep.2021. ...

A team of researchers from the Changchun Institute of Applied Chemistry has developed a nanogel-based strategy to enhance the ...

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of ...

Prof. LIANG Xingjie's team from the National Center for Nanoscience and Technology, along with Prof. GONG Ningqiang from the University of Science and Technology of China, has developed a biomimetic ...

One therapy being pursued to establish effective antitumor immunity is adoptive T-cell ... et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells.

Most patients who have a relapse after anti-CD19 CAR T-cell therapy or have resistance to such therapy continue to have CD19 expression on malignant B cells. 11 Although CD19 antigen loss can ...

The less robust antitumor effects of CAR T-cell therapies when evaluated in patients with solid tumor malignancies have been attributed to the complex tumor microenvironment, antigen heterogeneity, ...

The current study, presented Monday, confirmed partial response in a heavily pretreated patient who did not respond to prior PD-1 therapy. Results showed more than 50% depletion of CCR8+ Tregs and ...